Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma | Citedby Results | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Shorter Treatment-Naïve Leukocyte Telomere Length is Associated with Poorer Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma

Cancer Epidemiol Biomarkers Prev (2021) 30 (1): 210–216.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase

Songting Shou
Yuanliang Li
Jiaqin Chen
Xing Zhang
Chuanlong Zhang
Xiaochen Jiang
Fudong Liu
Li Yi
Xiyuan Zhang
En Geer
Zhenqing Pu
Bo Pang

Cancer Gene Therapy (2024) 31 (9): 1292.

Objective assessment of the association between telomere length, a biomarker of aging, and health screening indicators: A cross-sectional study

Yiting Fu
Huiling Lou
Qiaocong Chen
Shu Wu
Hansen Chen
Kaixin Liang
Yuanlong Ge
Chunzhen Zhao

Medicine (2024) 103 (24): e38533.

Influence of Cancer Susceptibility Gene Mutations and ABO Blood Group of Pancreatic Cancer Probands on Concomitant Risk to First-Degree Relatives

Samuel O. Antwi
Kari G. Rabe
William R. Bamlet
Margaret Meyer
Shruti Chandra
Sarah E. Fagan
Chunling Hu
Fergus J. Couch
Robert R. McWilliams
Ann L. Oberg
Gloria M. Petersen

Cancer Epidemiology, Biomarkers & Prevention (2022) 31 (2): 372.